1-6 of 6
Taro Hitosugi
Close
Sort by
Journal Articles

Unraveling Antioxidative Metabolic Pathways in Multiple Myeloma: Augmenting IMiD Sensitivity through Intracellular Cysteine Biosynthesis Inhibition

Sinto Sebastian Chirackal, Taro Hitosugi, Gregory Ahmann, Esteban Braggio, Marta Chesi, P. Leif Bergsagel, Rafael Fonseca
Journal: Blood
Blood (2023) 142 (Supplement 1): 3291.
https://doi.org/10.1182/blood-2023-189785
Published: 2023
Journal Articles

Levels of Individual Mid and Long Chain Polyunsaturated Triacylglycerols (TAGs) Are Different between the Bone Marrow Microenvironment of Patients with Multiple Myeloma (MM) and Monoclonal Gammopathy of Unknown Significance (MGUS)

Yogesh Chawla, Emilie Anderson, Isas Rosario Vasquez, Rachel A Simon, Taro Hitosugi, Shaji Kunnathu Kumar, Wilson I. Gonsalves
Journal: Blood
Blood (2023) 142 (Supplement 1): 4708.
https://doi.org/10.1182/blood-2023-186983
Published: 2023
Journal Articles

Tfeb Links MYC Signaling to Epigenetic Control of Acute Myeloid Leukemia Cell Death and Differentiation

Seongseok Yun, MDPhD, Nicole D. Vincelette, PhD, Mario Fernandez, Xiaoqing Yu, PhD, Chunying Yang, Taro Hitosugi, PhD, Chia-Ho Cheng, PhD, Audrey Freischel, Ling Zhang, MD, Gregory Watson, PhD, Weimin Li, Hsin-An Hou, MD PhD, Franz Xaver Schaub, PhD, Alexis Vedder, BS, Ling Cen, PhD, Kathy McGraw, PhD, Daniel Murphy, PhD, Andrea Ballabio, Scott H. Kaufmann, MD PhD, Anders Berglund, John L. Cleveland, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 12–13.
https://doi.org/10.1182/blood-2020-137209
Published: 2020
Journal Articles

Phosphoglycerate Mutase 1 Promotes Leukemia Metabolism by Coordinating Glycolysis and Biosynthesis, and Represnts a Therapuetic Target in Leukemia Treatment

Taro Hitosugi, PhD, Lu Zhou, PhD, Jun Fan, PhD, Martha Arellano, MD, Hanna J. Khoury, MD, Benjamin H. Lee, MD, PhD, Titus Boggon, PhD, Sumin Kang, PhD, Chuan He, Jing Chen, PhD
Journal: Blood
Blood (2012) 120 (21): 860.
https://doi.org/10.1182/blood.V120.21.860.860
Published: 2012
Journal Articles

Leukemogenic Tyrosine Kinases Inhibit PKM2 to Promote the Warburg Effect and Tumor Growth

Taro Hitosugi, PhD, Sumin Kang, PhD, Matthew Vander Heiden, MD/PhD, Tea-wook Chung, PhD, Shannon Elf, Katherine Lythgoe, Shaozhong Dong, PhD, Sagar Lonial, MD, Xu Wang, PhD, Georgia Chen, PhD, Jianxin Xie, PhD, Ting-Lei Gu, PhD, Roberto Polakiewicz, PhD, Johannes L. Roesel, PhD, Titus Boggon, PhD, Fadlo Khuri, MD, D. Gary Gilliland, MD, PhD, Lewis Cantley, PhD, Jonathan L. Kaufman, MD, Jing Chen, PhD
Journal: Blood
Blood (2010) 116 (21): 3142.
https://doi.org/10.1182/blood.V116.21.3142.3142
Published: 2010
Journal Articles

FGFR3 Associates with and Tyrosine-Phosphorylates p90RSK2, Leading to RSK2 Activation That Mediates Hematopoietic Transformation

Sumin Kang, Shannon Elf, Shaozhong Dong, Taro Hitosugi, Ailan Guo, Hong Ruan, Sagar Lonial, Hanna Khoury, Ifor Williams, Gerard Karsenty, André Hanauer, Ting-Lei Gu, Jing Chen
Journal: Blood
Blood (2008) 112 (11): 3722.
https://doi.org/10.1182/blood.V112.11.3722.3722
Published: 2008